# Use of Tranexamic Acid in Reduction Mammoplasty

> **NCT04947514** · PHASE4 · COMPLETED · sponsor: **Montefiore Medical Center** · enrollment: 98 (actual)

## Conditions studied

- Hematoma Postoperative
- Venous Thromboembolism

## Interventions

- **DRUG:** Tranexamic acid
- **OTHER:** Placebo (topical saline)

## Key facts

- **NCT ID:** NCT04947514
- **Lead sponsor:** Montefiore Medical Center
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2021-10-29
- **Primary completion:** 2022-07-13
- **Final completion:** 2022-07-13
- **Target enrollment:** 98 (ACTUAL)
- **Last updated:** 2023-04-10

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04947514

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04947514, "Use of Tranexamic Acid in Reduction Mammoplasty". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT04947514. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*